Le Lézard
Classified in: Health
Subject: SVY

The global disruptive behavior disorder treatment market size is expected to reach USD 24.0 billion by 2026


NEW YORK, Nov. 14, 2018 /PRNewswire/ -- Disruptive Behavior Disorder (DBD) Treatment Market Size, Share & Trends Analysis Report By Type (Oppositional Defiant, Conduct), By Treatment (Parenting, Individual), By Region, And Segment Forecasts, 2018 - 2026

Read the full report: https://www.reportlinker.com/p05620889

The global disruptive behavior disorder treatment market size is expected to reach USD 24.0 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 4.9% during the estimated period. Increasing cases of substance abuse across the globe are considered to be the key factors driving the market. Drug abuse is one of the major causes for acquiring oppositional defiant and conduct disorder as it enhances the symptoms for such conditions. Rising prevalence of mental disorders among children and teenagers is leading to increased awareness regarding the associated treatments, there by augmenting the market growth.

For instance, according to the Substance Abuse and Mental Health Services Administration (SAMHSA), globally, around 3.0% of children suffer from Oppositional Defiant Disorder (ODD) and around 8.0% of children suffer from Conduct Disorder (CD) per year. In recent times, majority of the parents of children aged between 5 and 14 years have undergone workshops and trainings for the treatment of above-mentioned conditions. Several hospitals, clinics, and institutes are organizing campaigns to create awareness about the relevant treatments among parents and physicians. For instance, the Child Mind Institute, Inc., organized a campaign named Speak Up for Kids, in May 2018, where children's mental health issues and various treatments and policies related to these disorders were discussed. Therefore, such initiatives are expected to bolster the market growth over the forecast period.

Further key findings from the study suggest:
? In terms of revenue, oppositional defiant disorder segment is projected to ascend at a CAGR of 5.4% over the forecast period
? Increasing prevalence of such problems and awareness regarding their treatments will drive this segment
? Parenting therapy is expected to witness the fastest growth over the forecast period
? Frequent recommendation of parenting therapy by doctors, as it allows rapid recovery and is easy to follow, is expected to drive the segment
? Asia-Pacific market is expected to witness the fastest growth over the forecast period owing to the increasing cases of substance abuse
? Some of the key companies in the global disruptive behavior disorder treatment market are Highland Ridge Hospital, Lakeview Health, Boston Children's Hospital, INTEGRIS Health.

Read the full report: https://www.reportlinker.com/p05620889

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 07:45
Redwood Scientific Technologies Inc. ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities. The New York-based firm will only focus on enhancing and expanding its nicotine...

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that as part of its commitment to advancing patient care the company has opened a new training center in...

at 07:30
The "Drug Delivery Companies Compendium 2024" directory has been added to ResearchAndMarkets.com's offering. The Drug Delivery Companies Compendium is a cost-effective, time-saving product that answers all of your questions about Drug Delivery...

at 07:30
Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it has scheduled its...

at 07:30
Biomed Israel, the premier international Life Science and HealthTech conference in Israel, will take place on May 21-23, 2024, at the David InterContinental Hotel in Tel Aviv, Israel. The event presents a unique opportunity for global healthcare and...



News published on and distributed by: